Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
10/2003
10/08/2003EP1349858A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
10/08/2003EP1349856A2 Isoindolin-1-one glucokinase activators
10/08/2003EP1349854A1 Hetaryl substituted homotetramic and homotetronic acids and the use thereof as pesticides
10/08/2003EP1349843A1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
10/08/2003EP1007517B1 Process for the preparation of 5-hydroxymethylthiazoles
10/08/2003EP0812319B9 2-arylbenzazole compounds
10/08/2003CN1447801A Continuous process for prepn. of pesticidal chorothiazoles
10/08/2003CN1447800A Catalytic process for prepn. of thiazole derivatives
10/08/2003CN1447791A 10-aryl-11-hbenzo [b] fluorene derivatives and analogs for medicinal use
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1447654A Compsns. for enhancing or improving flavor of foods or drinks and method or improving flavor of foods or drinks by using same
10/07/2003US6630512 Cell adhesion inhibitors
10/07/2003US6630493 Heterocyclically substituted amides, their preparation and use
10/07/2003US6630461 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders
10/07/2003CA2263957C Diarylmethyl piperazine derivatives as delta opioid agonists
10/07/2003CA2223418C Polyoxyhydrocarbyl related products and methods for fluorescence assays
10/02/2003WO2003080828A2 Nucleic acid molecules involved in the synthesis of melithiazols
10/02/2003WO2003080585A1 Novel aminobenzamide derivative
10/02/2003WO2003080545A2 Substituted phenylacetic acids
10/02/2003WO2003080042A1 Decomposition inhibitor for extracellular matrix of cartilage
10/02/2003WO2003080041A1 Remedies for arthritis deformans
10/02/2003WO2003080038A1 Preventive or therapeutic agent for kidney disease
10/02/2003WO2003044015A3 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
10/02/2003US20030187273 Anticancer agents; antiproliferative agents
10/02/2003US20030187259 Heterocylic fluoroalkenyl thioethers and the use thereof as pesticides (IV)
10/02/2003US20030187235 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
10/02/2003US20030187047 Vision defects; non-insulin diabetic agents; impotency; dietetics
10/02/2003US20030187042 Modulate gene expression; antitumor agents; cardiovascular disorders; anticholesterol agents; antilipemic agents
10/02/2003US20030187040 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
10/02/2003US20030187033 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents
10/02/2003US20030187015 Viricides; anticancer agents
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030186988 Lymphocyte disease; autoimmune disease
10/02/2003US20030186985 Oxyiminoalkanoic acid derivatives
10/02/2003US20030186974 Pyrrolyl- and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
10/02/2003US20030186941 Cyclopenteneone derivatives
10/02/2003CA2488161A1 Novel aminobenzamide derivative
10/02/2003CA2479338A1 Substituted phenylacetic acids
10/02/2003CA2479254A1 Preventive or therapeutic agent for renal disease
10/01/2003EP1348709A2 Thiazolo (4,5-D) pyrimidine compounds
10/01/2003EP1348701A1 (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
10/01/2003EP1348433A1 Thiazol-2-yl-imine compounds as PDE-7 inhibitors
10/01/2003EP1347971A1 Thiazolyl inhibitors of tec family tyrosine kinases
10/01/2003EP1347969A1 5- (pyrazol-4-yl)carbonyl]benzazolone as herbicide
10/01/2003EP1347968A1 Lfa-1 antagonist compounds
10/01/2003EP1206472B1 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
10/01/2003CN1446204A Method for purifying 2-chloro-5-chloromethyl thiazole
10/01/2003CN1122665C Herbicidal N-alkenyl heteroaryloxyacetamides
09/2003
09/30/2003US6627767 Controlling cellular metabolism
09/30/2003US6627640 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
09/30/2003US6627638 Viricides, anticarcinogneic agents
09/30/2003US6627627 Aralkyl and aralkylidene heterocyclic lactams and imides
09/30/2003CA2102697C Pyrrolidine derivatives, preparation thereof and drugs containing same
09/25/2003WO2003078440A1 Broad-spectrum cephem compounds
09/25/2003WO2003078413A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
09/25/2003WO2003078412A1 Process forpreparation of alkoxybenzamides and thiazolyl isocyanates
09/25/2003WO2003078411A1 C3-cyano epothilone derivatives
09/25/2003WO2003077862A2 Potent, simplified derivatives of immunosuppressive agents
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2003077828A2 Novel florfenicol-type antibiotics
09/25/2003WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof
09/25/2003WO2002100818A3 Aminediols as agents for the treatment of alzheimer's disease
09/25/2003US20030181718 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
09/25/2003US20030181717 R-isomers of nonnucleoside inhibitors
09/25/2003US20030181499 For use as anti-human immunodeficiency virus (HIV) drugs
09/25/2003US20030181494 For lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels; useful for therapy of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer
09/25/2003US20030181479 Treating ischemic arrhythmia, myocardial ischemia and infarction, asthma, rhinitis, pain, gastrointestinal disorders; a histamine H3 receptor agonistic activity
09/25/2003US20030181391 Dipeptide apoptosis inhibitors and the use thereof
09/25/2003US20030181390 Sustained release of aminobutyric acid using prodrugs such as L-1-naphthylalanine-gabapentin, administered for prophylaxis of nervous system disorders, as anxiolytics, antidepressants or antiinflammatory agents; drug delivery
09/25/2003US20030181352 Substituted heterocyclic compounds
09/25/2003US20030181319 Process for preparing nonracemic chiral alcohols
09/25/2003US20030181318 Process for preparing nonracemic chiral alcohols
09/25/2003US20030180635 Visible radiation sensitive composition
09/25/2003CA2479354A1 Broad-spectrum cephem compounds
09/25/2003CA2478048A1 Novel florfenicol-type antibiotics
09/24/2003EP1345916A1 Substituted oxazoles and thiazoles as hppar alpha agonists
09/24/2003EP1345915A1 Improved process for water soluble azole compounds
09/24/2003EP1345914A1 Therapeutic compounds
09/24/2003EP1345902A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
09/24/2003EP1345890A1 Glucagon antagonists/inverse agonists
09/24/2003EP1345598A2 The use of ppar-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired plasticity
09/24/2003EP1100802B1 OXAZOLO, THIAZOLO AND SELENAZOLO [4,5-c]-QUINOLINE-4-AMINES AND ANALOGS THEREOF
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003EP0914122B1 Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone
09/24/2003CN1444584A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444572A 2-aminothiazoline derivatives and their use as no-synthase inhibitors
09/24/2003CN1444564A Biphenyl carboxamides
09/24/2003CN1443760A Preparation method of carboxyalkyl lotanning
09/24/2003CN1122018C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
09/23/2003US6624310 Epothilone minor constituents
09/23/2003US6624197 Styrene administered orally to decrease blood glucose levels in rats. The glucose tolerance in insulin resistant rats is also shown, as well as lowering of triglyceride levels in serum insulin resistant, hyperinsulinemic and
09/23/2003US6624188 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
09/23/2003US6624186 Modulators of SKCa, IKCa and BKCa channels.
09/23/2003US6624182 Hydroxyphenylvinylthiazoles
09/23/2003US6624163 P-acylaminomethyl-N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2 -yl)-benzamides; treatment of diseases related to the adenosine receptor, such as Alzheimer's disease, depression, drug addiction, Parkinson's and Attention Deficit Hyperactivity Disorder
09/23/2003US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases
09/23/2003US6623930 Contacting cell with non-nucleoside compounds that interact with specific DNA structures and which inhibit human telomerase reducing proliferative capacity of a cell
09/23/2003CA2127110C Carbamates and crop protection agents containing them
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
1 ... 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 ... 337